Baxter International Inc. (NYSE: BAX) has significant potential for a rise, and according to analysts, it has secured a place on its list of 12 Best Widow and Orphan stocks.
On September 26, 2025, Baxter International Inc. (NYSE: BAX), a leading Global Medtech company, was awarded a gold-level resilience badge by the Healthcare Industry Resilience Collaboration (HIRC) through IV Solutions, Nutrition Solutions and Premix Drugs. This is the first time a manufacturer has been recognized at this level in these categories, reflecting Baxter's efforts to enhance the resilience of the medical supply chain.
This recognition follows a comprehensive review of HIRC's Baxter International Inc. (NYSE: BAX) resilience measurements, followed by a comprehensive review of HIRC's Baxter International Inc. (NYSE: BAX) resilience measurements, followed by a proactive inventory management, enhanced risk forecasting, a robust cybersecurity framework, and real-time logistical visibility through a control tower system. The award was built with Baxter's previous transparency badges in 2023 and 2024, and with the launch of the Welch Allyn Connex 360 Vital Signs Monitor earlier this month, expanding its connected surveillance product line.
Baxter International Inc. (NYSE: BAX) operates through its pharmaceutical, healthcare systems and technology, medical products and therapy divisions, providing a wide range of healthcare products in the United States and around the world. It is one of the best widows and orphan strains.
Although we acknowledge the potential of BAX as an investment, we believe certain AI stocks offer greater promotion potential and pose a risk of decline. If you're looking for a highly underrated AI stock that can make a significant profit from the tariff and supervision trends of the Trump era, check out our free report on the best short-term AI stocks.
Read next: Buy 15 stocks and 12 best quantum computing stocks that benefit from AI and 12 best quantum computing stocks, according to Wall Street analysts.
Disclosure: None.
